Cogent Biosciences Inc. (cogt 1.625 11/15/31)
13F holders, Q2 2026 (June 30)1holders −2
0new positions
2sold out
$1.24avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Cogent Biosciences Inc. (cogt 1.625 11/15/31) in their 13F filings, down 2 from Q1 2026. 0 opened new positions and 2 sold out. The largest holder was Jupiter Topco LLC ($4.9M).
- Company
- Cogent Biosciences Inc. (cogt 1.625 11/15/31)
- CUSIP
- 19240QAA0
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $10.0M |
All 13F filers, Q1 2026 → Q2 2026: 8,153,000 shares sold, net −8,153,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Jupiter Topco LLC | 0.00% | — | 3,922,000 | $4.9M |
"% of holder's portfolio" is COGENT BIOSCIENCES INC (COGT 1.625 11/15/31)'s weight in each manager's 13F, not the share of Cogent Biosciences Inc. (cogt 1.625 11/15/31) the manager owns.